Compensation claims after knee arthroplasty surgery in Norway 2008–2018 by Randsborg, Per-Henrik et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=iort20
Acta Orthopaedica
ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/iort20
Compensation claims after knee arthroplasty
surgery in Norway 2008–2018
Per-Henrik Randsborg , Tommy Frøseth Aae , Ida Rashida Khan Bukholm ,
Anne Marie Fenstad , Ove Furnes & Rune Bruhn Jakobsen
To cite this article: Per-Henrik Randsborg , Tommy Frøseth Aae , Ida Rashida Khan
Bukholm , Anne Marie Fenstad , Ove Furnes & Rune Bruhn Jakobsen (2021): Compensation
claims after knee arthroplasty surgery in Norway 2008–2018, Acta Orthopaedica, DOI:
10.1080/17453674.2020.1871187
To link to this article:  https://doi.org/10.1080/17453674.2020.1871187
© 2021 The Author(s). Published by Taylor &
Francis on behalf of the Nordic Orthopedic
Federation.
Published online: 13 Jan 2021.
Submit your article to this journal 
Article views: 491
View related articles 
View Crossmark data
Acta Orthopaedica 2020; 91 (x): x–x 1
Compensation claims after knee arthroplasty surgery in Norway 
2008–2018
Per-Henrik RANDSBORG 1,6, Tommy Frøseth AAE 2, Ida Rashida Khan BUKHOLM 3, Anne Marie FENSTAD 4, 
Ove FURNES 4,7, and Rune Bruhn JAKOBSEN 1,5  
1 Department of Orthopaedic Surgery, Akershus University Hospital, Lørenskog, Norway; 2 Department of Orthopedic Surgery, Health Møre and Romsdal 
HF, Kristiansund Hospital, Kristiansund, Norway; 3 Norwegian System of Patient Injury Compensation, Oslo, Norway; 4 Norwegian Arthroplasty Register, 
Department of Orthopaedic Surgery, Haukeland University Hospital, Bergen, Norway; 5 Department of Health Management and Health Economics, 
Medical Faculty, University of Oslo, Oslo, Norway; 6 Sports Medicine Institute, Hospital for Special Surgery, New York, USA; 7 Department of Clinical 
Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway
Correspondence: pran@ahus.no
Submitted 2020-09-24. Accepted 2020-10-15.
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of the Nordic Orthopedic Federation. This is an 
Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits 
 unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI 10.1080/17453674.2020.1871187
The number of knee arthroplasty procedures in Norway has 
increased over the last decade and is now over 7,000 per year 
(Ackerman et al. 2017, NAR 2020). About 1 in 5 patients 
receiving a TKA remains dissatisfied with the result (Gunara-
tne et al. 2017). Although serious complications are rare, 
infections, implant loosening, misplaced implants, residual 
pain, and other complications do occur, with potential detri-
mental results. To monitor the safety of implants and define 
the epidemiology of the procedures, the Norwegian Arthro-
plasty Register (NAR) was established in 1987 (Havelin et 
al. 2000). NAR provides a comprehensive overview of knee 
arthroplasties taking place in Norway. Compliance with the 
registry is 97.6% for primary TKA and 93.2% for revisions 
(Wiik 2014). 
Patients who suffer an injury while receiving health ser-
vices, within either the public or the private healthcare sector, 
can file a claim with the Norwegian System of Patient Injury 
Compensation (NPE). 3 criteria must be fulfilled for a claim 
to be accepted:
1. The injury must have been caused during health services 
(diagnosis, examination, treatment, care, or lack of such), even 
if no one is to blame. If the injury is severe and unexpected, 
compensation may be awarded even where no error or omis-
sion in treatment has occurred (for example if infection occurs 
despite adequate prophylaxis).
2. The injury must have caused financial loss to the patient, 
except if the injury leads to permanent medical impairment 
of more than 15%, in which case compensation might be 
awarded despite financial loss. This might be relevant for 
retired patients or for patients who can continue to work in 
spite of the disability.
Background and purpose — Orthopedic surgery is 
one of the specialties with most compensation claims. We 
assessed the claims following knee arthroplasty surgery 
reported to the Norwegian System of Patient Injury Com-
pensation (NPE) in light of institutional procedure volume.
Patients and methods — We collected data from 
NPE and the Norwegian Arthroplasty Register (NAR) for 
the study period (2008–2018). Age, sex, type of claim, and 
reason for compensation were collected from NPE, while the 
number of arthroplasty surgeries was collected from NAR. 
The treating hospitals were grouped by quartiles according 
to annual procedure volume. The effect of hospital volume 
on the likelihood of an accepted claim was estimated.
Results — NAR received 64,241 reports of arthroplasty 
procedures, of which 572 (0.9%) patients filed a claim for 
treatment injury. 55% of the claims were accepted, repre-
senting 0.5% of all knee arthroplasties. The most common 
reason for accepted claim was a hospital-acquired infection, 
in 28% of the patients, followed by misplaced implant (26%) 
and aseptic loosening (13%). The hospitals with the lowest 
annual volume (57 or fewer arthroplasties per year, first quar-
ter) had a statistically significantly larger fraction of granted 
claims per procedures compared with other institutions.
Interpretation — The overall risk of ending up with com-
pensation due to treatment error following knee arthroplasty 
was 0.5%. The risk of accepted claim was greater for patients 
operated in the lowest volume hospitals.
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3. The patient must file a claim within a reasonable time 
(currently set at 3 years) after the patient realizes that the 
injury is caused by the treatment or lack of treatment received. 
The claim is filed with NPE at no cost to the patient.
There is compelling evidence that low surgical volume 
increases the risk of complications and revision after knee 
arthroplasty surgery (Jaeschke et al. 1989, Badawy et al. 2013, 
Pamilo et al. 2015, Badawy et al. 2017). Whether this associa-
tion is also true for injury compensation has not been studied. 
We evaluated the claims following primary and revision knee 
arthroplasty surgery filed with NPE and compared the findings 
with the results from NAR with a focus on annual hospital 
procedure volume.
Patients and methods
Data from NAR was collected for the study period (2008 
through 2018). The data was stratified by the number of 
arthroplasty procedures performed annually per hospital. The 
hospitals were then divided into quarters according to aver-
age annual procedure volume. The lowest quarter (Q1) rep-
resented 6 institutions with ≤ 57 knee arthroplasty procedures 
per year. The 2nd quarter (Q2) consisted of 8 institutions with 
an annual volume of 58–168 procedures, the 3rd quarter (Q3) 
included 8 institutions with an annual volume of 169–304 pro-
cedures, and finally the 4th quarter (Q4) contained 7 institu-
tions with 305 or more knee arthroplasty procedures per year. 
All claims filed with NPE following knee arthroplasty sur-
geries that were performed during the study period were col-
lected. The data were stratified by institution, the patient’s age, 
sex, type of complication, and any reoperations. The reason 
for the claim was recorded, together with the decision made 
by NPE (accepted or rejected claim).
Statistics
Continuous variables are presented as mean, median, 95% 
confidence interval (CI), range, and standard deviation (SD), 
while categorical data is presented in frequencies. Groups 
were hence compared using the 2-sample independent t-test or 
the chi-square test. We compared the institutions by procedure 
volume using ANOVA after asserting conditions were met, 
and p-values adjusted for multiple testing by Tukey’s compari-
son test. Associations were quantified by odds ratio. A p-value 
< 0.05 was considered statistically significant. The analysis 
was performed using the Statistical Package for Social Sci-
ences (SPSS) version 25 (IBM Corp, Armonk, NY, USA).
Ethics, funding, and potential conflicts of interest
The Regional Ethical Committee (REK) has deemed approval 
not necessary as all data are based on already anonymized 
records (REK 15.10.10). This study received no external fund-
ing. The authors declare no conflicts of interests.
Results
During the study period 2008–2018, 64,241 knee arthroplasty 
procedures were reported to NAR. There were 59,109 primary 
knee arthroplasties, of which 6,788 (12%) were unicompart-
mental knee arthroplasties (UKA). There were 5,132 (8%) 
revision arthroplasties.
NPE received 572 claims for treatment injuries related to 
arthroplasties performed during these years, representing 
0.9% of all knee arthroplasty procedures. The average age at 
the time of surgery for the claimants was 62 (range 24–86) 
years, and 57% of the claims were filed by women (Table 1). 
312 (55%) claims were accepted, representing 0.5% of all 
knee arthroplasties reported to NAR in the period. 259 of the 
claims were accepted following a primary TKA (0.5% of 
all primary TKAs) and 25 claims were accepted following a 
UKA (0.4% of all UKAs, p = 0.2). 11 claims were accepted 
after revision arthroplasties (0.2% of all revisions) (Table 2).
Table 1. Demography of knee arthroplasty procedures reported to the Nor-
wegian Arthroplasty Registry (NAR) and compensation claims filed with the 
Norwegian System of Patient Injury Compensation (NPE) during 2008–2018 
 Knee 
 procedures Compensation Accepted Rejected 
 reported claims filed claims claims
 to NAR to NPE n = 312 n = 260 
Factor n = 64,241 n = 572 (54.5%) (45.5%) p-value a
Mean age (SD)  68 (9.7) 62 (10) 63 (9.9) 61 (11) 
 range 12–101 24–86 38–86 24–85 
Females, n (%) 38,352 (60) 324 (57) 169 (54) 155 (60) < 0.001
SD, standard deviation. 
a Chi-square test comparing proportion of women reported to NAR with pro-
portion of women filing a complaint to NPE.
Table 2. Distribution of implant type among 312 
accepted compensation claims from the Norwegian 
System of Patient Injury Compensation during 2008–
2018
Implant type Number (%)
Primary total knee arthroplasty
 cemented 225 (72)
 non-cemented 23 (7)
 hybrid technique 21 (7)
Primary unicondylar knee arthroplasty
 cemented 21 (7)
 non-cemented 4 (1)
Primary patellofemoral arthroplasty
 cemented 1 (0.3)
 non-cemented 1 (0.3)
Secondary total knee arthroplasty
 cemented 9 (3)
 hybrid technique 2 (0.6)
Secondary patellofemoral arthroplasty 
 cemented 1 (0.3)
Other, unspecified 4 (1)
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The most common reason for accepted claim was a hospi-
tal-acquired infection, in 87 (28%) patients, followed by mis-
placed implant (81 patients, 26%), and aseptic loosening (40 
patients, 13%). Nearly 9% of the claims were accepted due to 
the wrong indication (Table 3).
15 of 27 claims from private institutions were accepted, 
compared with 248 (46%) of 545 claims from public hospitals 
(p = 0.9). 
2 claims involving fatalities were recorded, both related to 
thrombosis prophylaxis. A 78-year-old male undergoing a pri-
mary cemented TKA was given low molecular weight heparin 
while also taking celecoxib, and died from a bleeding gastric 
ulcer. A 64-year-old male with known increased thrombotic 
risk received a hybrid primary TKA. He did not receive guide-
line anticoagulation, and died of acute cerebral stroke. In both 
cases NPE granted compensation to the survivors.
Hospital procedure volume
The lowest volume hospitals (< 57 arthroplasties per year, 
Q1) had a statistically significantly larger fraction of accepted 
claims per procedures compared with other institutions 
(Figure). The odds ratio for receiving compensation after a 
knee arthroplasty performed in a low-volume hospital (Q1) 
was 3 (CI 2–5) compared with surgery performed in a hospital 
with higher procedure volume (Table 4). There were no sta-
tistically significant differences in accepted claims per annual 
procedure volume between the other 3 procedure volume 
quarters (Q2–Q4).
When considering all claims filed, the lowest volume quar-
ter (Q1) had a similar ratio of accepted claims compared with 
the 2 highest volume quarter (Q3 and Q4). The 2nd quarter 
(Q2) had a lower ratio of accepted claims compared with Q1 
and Q3 (Table 5).
Discussion 
Our main finding is that patients operated on in the lowest 
volume hospitals have a 3-fold risk of being granted a com-
pensation claim following knee arthroplasty surgery com-
pared with patients being treated in higher volume institu-
Table 3. Reasons for accepted claims for treatment injuries follow-
ing knee arthroplasty surgeries in Norway during 2008–2018. Values 
are count (%) 
  All cases TKA UKA PFA
Reason for accepted claim n = 312 n = 284 n = 25 n = 3
Hospital-acquired infection 87 (28) 75 (26) 11 1
Misplaced implant 81 (26) 77 (27) 4 -
Early aseptic loosening a 40 (13) 37 (13) 3 -
Wrong indication 27 (9) 23 (8) 3 1
Wrong choice of implant 12 (4) 10 (4) 2 -
Peroperative nerve injury 12 (4) 11 (4) - 1
Inadequate follow-up 10 (3) 10 (4) - -
Peroperative vascular injury 10 (3) 10 (4) - -
Peroperative tendon/
 ligament injury 9 (3) 8 (3) 1 -
Wrong or inadequate 
 antithrombotic prophylaxis 4 (1) 4 (1) - -
Peroperative fracture 4 (1) 4 (1) - -
Nerve injury due from 
 bandage/cuff 3 (1) 3 (1) - -
Pain 3 (1.0) 3 (1) - -
Delayed treatment 3 (1.0) 3 (1) - -
Wrong technique 3 (1.0) 2 (0.5) 1 -
Radial nerve damage from 
 patient positioning  1 (0.3) 1 (0.3) - -
Burn injury from diathermic plate 1 (0.3) 1 (0.3) - -
Decubitus from inadequate 
 postoperative care 1 (0.3) 1 (0.3) - -
Other 1 (0.3) 1 (0.3) - -
TKA, total knee arthroplasty; UKA, unicompartmental knee arthro-
plasty; PFA, patellofemoral arthroplasty.
a Within 3 years.
Proportion of accepted claims by number of surgeries stratified by 
annual hospital procedure volume. The 4 categories represent quar-





p = 1.0 p = 1.0
p = 1.0








Q1 Q2 Q3 Q4
Table 4. Risk of accepted compen-
sation claims from the Norwegian 
System of Patient Injury Compen-
sation during 2008–2018 by annual 
procedure volume divided into 
quarters 
 
Quarter (Q) Odds ratio (95% CI)
Q1 vs, all others  3.0 (2.0–4.5)
Q1 vs. Q2 2.7 (1.7–4.4)
Q1 vs. Q3 2.6 (1.7–4.1)
Q1 vs. Q4 3.4 (2.2–5.2)
Q2 vs. Q3 1.0 (0.7–1.4)
Q2 vs. Q4 1.3 (0.9–1.8)
Q3 vs. Q4 1.3 (1.0–1.7)
Q1, ≤ 57 annual procedures; 
Q2, 58–168 annual procedures; 
Q3, 169–304 annual procedures; 
Q4, ≥ 305 annual procedures.
CI, confidence interval.
Table 5. Proportion of 
accepted claims (accepted 
claims/total claims) for each 
quarter of annual procedure 
volume
 Accepted/
Quarter total claims (%)
Q1 26/41   (63)




Q1–Q4, see Table 4
a Omnibus chi-square statistic 
was significant at p = 0.02. 
Analysis of adjusted stan-
dardized residuals revealed 
Q2 to be the main contributor 
with a z-score of 3.0.
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tions. Overall, about 0.5% of knee arthroplasty patients were 
compensated by NPE due to treatment failure. 
The main reason for compensation was hospital-acquired 
infection. This is also the most common reason for accepted 
claims after other elective knee procedures, such as anterior 
cruciate ligament reconstruction and cartilage surgery (Rands-
borg et al. 2018, Aae et al. 2020). The proportion of accepted 
claims due to infection was particularly high for UKA com-
pared with TKA (p = 0.06). Nearly 60% of knee arthroplas-
ties reported to NAR are performed on women, yet only 57% 
of compensation claims were filed by women. This small but 
statistically significant difference might be explained by the 
fact that men have a 2-fold increased risk of revision due to 
deep infection (Badawy et al. 2017). Normally, an error in the 
healthcare provided is needed for a claim to be accepted. How-
ever, an exception is made for severe and rare complications, 
even if no treatment error has been identified. This explains 
the high rate of compensation following infection and early 
(within 3 years) aseptic loosening found in our study. 
From a surgical point of view, it is interesting that mis-
placed implant is the 2nd greatest reason for compensation, 
representing over a quarter of the accepted claims. More 
claims from patients treated at the lowest volume hospitals 
may relate to the fact that both surgical and hospital volume 
affects clinical results and complication rates (Soohoo et al. 
2006, Paterson et al. 2010, Badawy et al. 2013, Pamilo et al. 
2015). Furthermore, it is worth noting that nearly 9% of the 
claims were accepted due to the wrong indication. The rela-
tive success of knee arthroplasty must not lead clinicians to 
utilize a one-size-fits-all solution for knee pain. The propor-
tion of claims accepted due to the wrong indication or wrong 
choice of implant was particularly high for UKA compared 
with TKA, but did not reach statistical significance. Never-
theless, our findings serve as a reminder that nonoperative 
measures and correlation between radiological findings and 
clinical symptoms remain cornerstones in the indication for 
knee arthroplasty (Schmitt et al. 2017). Unfortunately, avoid-
able treatment injuries such as wrong indication or inadequate 
follow-up remain major reasons for accepted claims in ortho-
pedic surgery (Randsborg et al. 2018, Aae et al. 2020). These 
are modifiable factors and demonstrate how compensation 
claim reports can be useful for clinicians to learn from other 
people’s mistakes. By focusing on proper indication, surgical 
technique, and follow-up routine, the number of adverse out-
comes and thus compensation claims will likely be reduced. 
Another interesting finding in our study is that the risk of 
compensation following primary UKAs was not higher than 
for primary TKAs. This came as some surprise to us, because 
the revision rate for UKAs is higher than for TKAs (Chawla 
et al. 2017, Arias-de la Torre et al. 2019, Jennings et al. 2019). 
However, the likelihood of compensation is not identical to 
the risk of complication. For a claim to be accepted, a treat-
ment failure must have occurred. A revision of a UKA does 
not necessary indicate that the primary surgery was a treat-
ment error. There is a lower threshold for surgeons to revise 
a painful UKA (Johnson et al. 2020), which may explain the 
higher rate of revision of UKA, but no difference in likelihood 
of treatment injury compensation.
Procedure volume has been a hot topic since 1979, when Luft 
et al. asked the simple question: Should operations be region-
alized? The effect on both hospital and surgeon volume on 
adverse outcome has been discussed across medical fields since 
then, and there is little doubt that very low volume increases 
risk of adverse outcome. For knee arthroplasties in particular, 
several authors have concluded that surgery performed in a low-
volume hospital increases the risk of adverse outcome (Soohoo 
et al. 2006, Paterson et al. 2010, Badawy et al. 2013, Pamilo et 
al. 2015). Our study confirms that the likelihood of compen-
sation due to treatment injury following knee arthroplasty is 
also increased in low-volume institutions. In support of this, a 
report from Finland found that hospital volumes of less than 
200 annual arthroplasty procedures were associated with more 
compensated treatment errors (Jarvelin et al. 2012). However, 
200 procedures per year would in our study place the hospital 
in the 2nd highest quarter. Therefore, our study provides a more 
detailed analysis of medium institutional procedure volume. 
Notably, only the lowest quarter (< 57 procedures per year) had 
a significant increased likelihood of accepted claims. 
Limitations
There are several limitations to this study. Some patients, 
who underwent surgery towards the end of the study period, 
may not yet have filed a compensation claim. There could be 
regional and institutional differences in the culture of claiming 
compensation or the information given to patients concern-
ing the possibility of filing a complaint. It is also likely that 
some treatment errors were never reported to NPE. Further-
more, individual surgeons’ annual procedure volume was not 
available, which could influence results. There could be some 
variation in annual procedure volume during the study period 
causing fluctuation between quarters. 
Our data is collected from a single country, with a public 
compensation scheme based on the principle of no blame. 
This is similar to systems in other Nordic countries, but dif-
ferent from countries such as the United Kingdom, the United 
States, Italy, and Germany that have a tort-based system. This 
may limit the generalizability of our study. However, our pur-
pose was not to compare different compensation schemes, but 
to analyze the causes and aspects of compensation following 
knee arthroplasty surgery. It is important to point out that this is 
not a study on complications following knee arthroplasty. Most 
complications will never be reported to NPE. A review of com-
pensation claims investigates the quality of the healthcare pro-
vided, not the outcome of the medical procedures in question. 
In summary, the overall likelihood of ending up with com-
pensation due to treatment error following knee arthroplasty 
was 0.5%. The likelihood was 3 times greater for patients 
operated on in the lowest volume hospitals.
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